According to Seelos Therapeutics 's latest financial reports the company's current EPS (TTM) is -$0.69. In 2022 the company made an earnings per share (EPS) of -$0.68 an increase over its 2021 EPS that were of -$0.77.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.69 | 1.47% |
2022 | -$0.68 | -11.69% |
2021 | -$0.77 | 75% |
2020 | -$0.44 | -90.16% |
2019 | -$4.47 | -70.16% |
2018 | -$14.98 | -229.04% |
2017 | $11.61 | -133.07% |
2016 | -$35.10 | -68.88% |
2015 | -$112.80 | -27.69% |
2014 | -$156.00 | 1.96% |
2013 | -$153.00 | -56.78% |
2012 | -$354.00 | 31.11% |
2011 | -$270.00 | -65.94% |
2010 | -$792.82 | -50.97% |
2009 | -$1,617 | 498.89% |
2008 | -$270.00 | -45.45% |
2007 | -$495.00 | -15.38% |
2006 | -$585.00 | -60.61% |
2005 | -$1,485 | -15.38% |
2004 | -$1,755 | -37.1% |
2003 | -$2,790 | -39.81% |
2002 | -$4,635 | 60.94% |
2001 | -$2,880 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$2.18 | 215.94% | ๐บ๐ธ USA |